ID   P3C2G_RAT               Reviewed;        1505 AA.
AC   O70173;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   24-JUL-2024, entry version 168.
DE   RecName: Full=Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma {ECO:0000305|PubMed:9516481};
DE            Short=PI3K-C2-gamma;
DE            Short=PtdIns-3-kinase C2 subunit gamma;
DE            EC=2.7.1.137 {ECO:0000269|PubMed:9516481};
DE            EC=2.7.1.154 {ECO:0000269|PubMed:9516481};
DE   AltName: Full=Phosphoinositide 3-kinase-C2-gamma;
GN   Name=Pik3c2g;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Regenerating liver;
RX   PubMed=9516481; DOI=10.1074/jbc.273.13.7731;
RA   Ono F., Nakagawa T., Saito S., Owada Y., Sakagami H., Goto K., Suzuki M.,
RA   Matsuno S., Kondo H.;
RT   "A novel class II phosphoinositide 3-kinase predominantly expressed in the
RT   liver and its enhanced expression during liver regeneration.";
RL   J. Biol. Chem. 273:7731-7736(1998).
CC   -!- FUNCTION: Generates phosphatidylinositol 3-phosphate (PtdIns3P) and
CC       phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) that act as
CC       second messengers (PubMed:9516481). May play a role in SDF1A-stimulated
CC       chemotaxis (By similarity). {ECO:0000250|UniProtKB:O70167,
CC       ECO:0000269|PubMed:9516481}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + ATP = a
CC         1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate) + ADP +
CC         H(+); Xref=Rhea:RHEA:12709, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57880, ChEBI:CHEBI:58088, ChEBI:CHEBI:456216;
CC         EC=2.7.1.137; Evidence={ECO:0000269|PubMed:9516481};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12710;
CC         Evidence={ECO:0000305|PubMed:9516481};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-
CC         phosphate) + ATP = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol-3,4-bisphosphate) + ADP + H(+); Xref=Rhea:RHEA:18373,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:57658,
CC         ChEBI:CHEBI:58178, ChEBI:CHEBI:456216; EC=2.7.1.154;
CC         Evidence={ECO:0000269|PubMed:9516481};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18374;
CC         Evidence={ECO:0000305|PubMed:9516481};
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:9516481}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:9516481}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in normal liver. High
CC       levels also found in regenerating liver. Very low levels found in heart
CC       and testis. {ECO:0000269|PubMed:9516481}.
CC   -!- DEVELOPMENTAL STAGE: Higher levels of expression found in adult liver
CC       than in fetal liver. {ECO:0000269|PubMed:9516481}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00879, ECO:0000255|PROSITE-ProRule:PRU00880}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB009636; BAA25634.1; -; mRNA.
DR   RefSeq; NP_446375.1; NM_053923.1.
DR   AlphaFoldDB; O70173; -.
DR   SMR; O70173; -.
DR   STRING; 10116.ENSRNOP00000043855; -.
DR   PhosphoSitePlus; O70173; -.
DR   PaxDb; 10116-ENSRNOP00000043855; -.
DR   GeneID; 116720; -.
DR   KEGG; rno:116720; -.
DR   UCSC; RGD:620231; rat.
DR   AGR; RGD:620231; -.
DR   CTD; 5288; -.
DR   RGD; 620231; Pik3c2g.
DR   eggNOG; KOG0905; Eukaryota.
DR   InParanoid; O70173; -.
DR   OrthoDB; 10350at2759; -.
DR   PhylomeDB; O70173; -.
DR   BRENDA; 2.7.1.137; 5301.
DR   BRENDA; 2.7.1.154; 5301.
DR   Reactome; R-RNO-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-RNO-1660514; Synthesis of PIPs at the Golgi membrane.
DR   PRO; PR:O70173; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005635; C:nuclear envelope; IDA:RGD.
DR   GO; GO:0005942; C:phosphatidylinositol 3-kinase complex; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IDA:UniProtKB.
DR   GO; GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0006935; P:chemotaxis; ISO:RGD.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; IBA:GO_Central.
DR   GO; GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IBA:GO_Central.
DR   CDD; cd04012; C2A_PI3K_class_II; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 2.
DR   Gene3D; 1.10.1070.11; Phosphatidylinositol 3-/4-kinase, catalytic domain; 1.
DR   Gene3D; 1.25.40.70; Phosphatidylinositol 3-kinase, accessory domain (PIK); 1.
DR   Gene3D; 3.30.1520.10; Phox-like domain; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR036940; PI3/4_kinase_cat_sf.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR002420; PI3K-type_C2_dom.
DR   InterPro; IPR001263; PI3K_accessory_dom.
DR   InterPro; IPR042236; PI3K_accessory_sf.
DR   InterPro; IPR000341; PI3K_Ras-bd_dom.
DR   InterPro; IPR015433; PI_Kinase.
DR   InterPro; IPR001683; PX_dom.
DR   InterPro; IPR036871; PX_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR10048:SF29; PHOSPHATIDYLINOSITOL 3-KINASE C2 DOMAIN-CONTAINING SUBUNIT GAMMA; 1.
DR   PANTHER; PTHR10048; PHOSPHATIDYLINOSITOL KINASE; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   Pfam; PF00792; PI3K_C2; 1.
DR   Pfam; PF00794; PI3K_rbd; 1.
DR   Pfam; PF00613; PI3Ka; 1.
DR   Pfam; PF00787; PX; 1.
DR   SMART; SM00239; C2; 2.
DR   SMART; SM00142; PI3K_C2; 1.
DR   SMART; SM00145; PI3Ka; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SMART; SM00312; PX; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF64268; PX domain; 1.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS51547; C2_PI3K; 1.
DR   PROSITE; PS00915; PI3_4_KINASE_1; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
DR   PROSITE; PS51546; PI3K_RBD; 1.
DR   PROSITE; PS51545; PIK_HELICAL; 1.
DR   PROSITE; PS50195; PX; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Chemotaxis; Kinase; Lipid metabolism; Membrane;
KW   Nucleotide-binding; Reference proteome; Transferase.
FT   CHAIN           1..1505
FT                   /note="Phosphatidylinositol 3-kinase C2 domain-containing
FT                   subunit gamma"
FT                   /id="PRO_0000088801"
FT   DOMAIN          278..370
FT                   /note="PI3K-RBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00879"
FT   DOMAIN          540..688
FT                   /note="C2 PI3K-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00880"
FT   DOMAIN          703..879
FT                   /note="PIK helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00878"
FT   DOMAIN          948..1226
FT                   /note="PI3K/PI4K catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   DOMAIN          1259..1371
FT                   /note="PX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00147"
FT   DOMAIN          1384..1505
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          1..32
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          954..960
FT                   /note="G-loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          1090..1098
FT                   /note="Catalytic loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          1109..1135
FT                   /note="Activation loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   COMPBIAS        13..32
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1505 AA;  170975 MW;  5ED4C2239968C4B2 CRC64;
     MAYNWQTEPN RAEPQEGGHD HQQCHHADQH LSSRQVRLGF DQLVEELSNK TPLPEDEKEG
     TCFVPDTPNL DSKWQSIYGP HPRHFNEFTS QSPHFSQLPF GKASAIGFNP AVLPAHQFIH
     EGASWRNPTR KYHGGEDPRF SALTPSSTGL DKCHQQGQSG TEHCNYYVEP ENNVPHHYSP
     YSMDSIPDSE EKGSGDADLV EPSLVFSKDS FLPRASENMS VESTEPIGCP LEIVEAPQGS
     NKSLASFCNN VTKIRGLYHA SDTNSNSGKI WAITTAYPSR LFADTQFRVK ISTDNSAQLL
     LLKPPANYLV KDLIAEILLL CANEQLSPKE YLLSICGSEE FLQTDHCLGS HKIFQKSKSV
     IQLHLQRSRD TPGKLSRKRD DDRSRVHLNQ LLEFTHIWKI SRQCLSTVMK SYNLHVEHLL
     KTQEDVEEKP LSSMFSCGRH PPQPHGNDII EDVRNICSVL GCIETKQVSD AVKELTLILQ
     RPSQNFHQNS ETSKKGFIEN VTSELSRSLH QLVDVYCSSF CTDFRPARAP GGVSRDHAGL
     HSHLSFTVCS LHNVPETWAH SYKAFSFSCW LTYAGKKLCQ VKSCRSLPVT KSFSFSVNWN
     EIINFPLEIK SLPRESMLVI KLFGIDSATH SANLLAWTCL PLFPKEKSPL GSRLLSMTLQ
     SEPPIEMMAP GVWDGSQPTP LTLQIDFPAA TWEYVKPETE ENRTDHQEPP RECLKHIARL
     SQKQPPLLLS VEKRRYLWFY RFYCNNENSS LPLVLGSAPG WDEGTVSEMH AVLRRWTFSH
     PLEALGLLTS RFPDQDIREV AVQQLDNFLT DELLDCLPQL VQAVKFEWSL ESPLVELLLH
     RSLQSIRVAH RLFWLLRDAQ GEDYFKSWYQ ELLAALQFCA GEALIEELSK EQKLVKLLGD
     IGEKVKSAGD AQRKDVLKKE IGSLEEFFKD IKTCHLPLNP ALCVKGIDRD ACSYFTSNAL
     PLKITFINAN PMGKNISVIF KAGDDLRQDM LVLQIIQVMD NVWLQEGLDM QMIIYGCLAT
     GKAQGFIEMV PDAVTLAKIH LHSGLIGPLK ENTIKKWFSQ HNHLKEDYEK ALRNFFYSCA
     GWCVVTFILG VCDRHNDNIM LTKSGHMFHI DFGKFLGHAQ TFGGIKRDRA PFIFTSEMEY
     FITEGGKNTQ HFQDFVELCC RAYNIVRKHS QLLLSLLEMM LHAGLPELRG IEDLKYVHDN
     LRPQDTDLEA TSHFTTKIKQ SLECFPVKLN NLIHTLAQMP AFSLARPAPQ TPPQECCVLN
     KTRTIQRVTI LGFSKTHSNL YLIEVTRSDN RKNLAKKSFE QFYRLHSQIQ KQFPLLTLPE
     FPHWWHLPFT DSHHERIRDL SHYVEQVLHG SYEVANSDCV LSFFLSEHIQ QTLEDSPFVD
     PGDHSPDKSP QVQLLMTYED TKLTILVKHL KNIHLPDGSA PSAHVEIYLL PHPSEVRRKK
     TKCVPKCTDP TYNEIVVYDD VSGLQGHVLM LIVKSKTVFV GAVNIQLCSV PLNEEKWYPL
     GNSII
//
